Search Login Register

miglustat (Zavesca) Summary

Description: a glucosylceramide synthase inhibitor

Also Known As: Zavesca; N-(n-butyl)deoxy-nojirimycin; N-(n-butyl)deoxynojirimycin; OGT 918; SC 48334 Show All >>

Networked: 155 relevant articles (21 outcomes, 38 trials/studies) for this Drug

Key Diseases for which miglustat is Relevant

  1. Gaucher Disease (Gaucher's Disease) : 7 outcomes 15 studies in 64 results
  2. Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) : 5 outcomes 6 studies in 33 results
  3. Neurologic Manifestations (Neurological Manifestations) : 2 outcomes 3 studies in 13 results
  4. Infection : 2 outcomes 1 study in 4 results
  5. Deglutition Disorders (Dysphagia) : 1 outcome 2 studies in 4 results
Show All >>

Drugs Related to miglustat

  1. miglustat (Zavesca)
  2. ceramide glucosyltransferase
  3. Glucosidases
  4. imiglucerase (Cerezyme)
  5. Dietary Sucrose (Table Sugar)
  6. Zidovudine (Retrovir)
  7. Maltose
  8. Lactose
  9. Ibuprofen (Motrin)
  10. Glycolipids
Show All >>

Therapies Related to miglustat

  1. Caloric Restriction
  2. Enzyme Replacement Therapy
  3. Enzyme Therapy
  4. Splenectomy
  5. Ketogenic Diet
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.